RankingsPricing
  1. JP-listed companies
  2. TAIKO PHARMACEUTICAL CO., LTD.
  3. Financials
  4. Common stock and paid-in capital

TAIKO PHARMACEUTICAL CO., LTD.【JP:4574】

Market cap
¥14.5B
P/E ratio
24.9x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCommon stock and paid-in capital (Million JPY)YoY (%)
Dec 31, 20245,007+1.03%
Dec 31, 20234,956+74.32%
Dec 31, 20222,843-0.21%
Dec 31, 20212,849+6.94%
Dec 31, 20202,664+17.29%
Mar 31, 20202,271+29.13%
Mar 31, 20191,759+11.85%
Mar 31, 20181,573+14.90%
Mar 31, 20171,369+67.30%
Mar 31, 2016818+27.93%
Mar 31, 2015639

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)